SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-003056
Filing Date
2017-04-28
Accepted
2017-04-28 16:11:30
Documents
3
Period of Report
2017-06-15
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231947zdef14a.htm DEF 14A 845375
2 G22642BGI001.JPG g22642bgi001.jpg GRAPHIC 136046
3 G22642BGI002.JPG g22642bgi002.jpg GRAPHIC 88163
  Complete submission text file 0001047469-17-003056.txt   1155620
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 17795652
SIC: 2835 In Vitro & In Vivo Diagnostic Substances